German Scientists Frequently Publish in Predatory Journals

At least 5,000 of the country’s researchers have published their work on questionable platforms, often forking over exorbitant fees, a report finds.

Jul 19, 2018
Catherine Offord

More than 5,000 German scientists have published their work in at least one predatory journal, internet platform, or conference, according to a joint report released today (July 19) by NDR and several other German news organizations. Predatory publishers exert limited, if any, editorial oversight of the content they produce, the report finds, and may charge authors—many of whom are supported by public funding—exorbitant prices for the opportunity.

The rise of predatory journals is a “disaster for science,” psychologist and University of Heidelberg ombudsman Joachim Funke tells NDR. “It allows unchecked claims to be promulgated and made to look like science.”

See “Identifying Predatory Publishers

During the 9-month investigation, a consortium of reporters from multiple organizations scanned 175,000 scientific articles published on five of the most prominent predatory platforms. The journalists found that in many cases, scientists appeared to have been tricked into using the systems, paying high fees in return for publication of their work on internet-based journals, most of which were run by companies based in South Asia, the Gulf region, Turkey, or Africa. 

The issue of predatory publishing extends far beyond Germany; according to the report, the problem may affect as many as 400,000 scientists worldwide.

The reporters identified several high-profile researchers in Germany, including University of Bremen President Bernd Scholz-Reiter and University of Hannover mechanical engineer Peter Nyhuis, who had coauthored multiple papers in these journals. Nyhuis, who is also a member of the German Council of Science and Humanities, tells NDR that he had “been unknowingly victimized by a system,” and says that he cut off all ties with the publishers after learning about their practices.

See “Opinion: Why I Published in a Predatory Journal

However, in some cases, scientists appear to have taken advantage of the lack of editorial oversight—most predatory publishers omit peer review altogether—to report their results quickly and without the risk of rejection. Gerd Antes, director of the medical nonprofit Cochrane Germany, tells NDR that he finds it “extremely irresponsible for reputable scientists to publish papers in outlets where disreputable authors are discernibly and intentionally given a platform, thereby enhancing their status.”

After the findings came to light, Anja Karliczek, Germany’s Federal Minister of Education and Research, called for an investigation into scientific publishing practices, Der Spiegel reports. Such an investigation is “in the interest of science itself,” she says (translated from German by She adds that everything must be done to ensure that “the credibility and the great trust in science do not suffer.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb


Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!